Include: Biospecimen reporting for improved study quality BRISQ - standard?

[CeciliaEngels]

I would like to suggest to have a quick look at the "Biospecimen reporting for improved study quality BRISQ guidelines" - just in order to make sure we do not miss out on anything: Cancer Cytopathology - 2011 - Moore - Biospecimen reporting for improved study quality BRISQ.pdf

If you agree that this suggestion makes sense, I would volunteer for it (though I would need a DoD ;)

Data Elements	Examples
Biospecimen type (Solid tissue, whole blood, or another product derived from a human being)	Serum, Urine
Anatomical site (Organ of origin or site of blood draw)	Liver, Antecubital area of the arm
Disease status of patients (Controls or individuals with the disease of interest)	Diabetic, Healthy control
Clinical characteristics of patients (Available medical information known or believed to be pertinent to the condition of the biospecimens)	Pre-menopausal breast cancer patients
Vital State of patients (Alive or deceased patient when biospecimens were obtained)	Postmortem
Clinical diagnosis of patients (Patient clinical diagnoses (determined by medical history, physical examination, and analyses of the biospecimen) pertinent to the study)	Breast cancer
Pathology diagnosis (Patient pathology diagnoses (determined by macro and/or microscopic evaluation of the biospecimen at the time of diagnosis and/or prior to research use) pertinent to the study)	Her2-negative intraductal carcinoma
Collection mechanism (How the biospecimens were obtained)	Fine needle aspiration, Pre-operative blood draw
Type of stabilization (The initial process by which biospecimens were stabilized during collection)	Heparin, On ice
Type of long-term preservation (The process by which the biospecimens were sustained after collection)	Formalin fixation, freezing
Constitution of preservative (The make-up of any formulation used to maintain the biospecimens in a non-reactive state)	10% neutral-buffered formalin, 10 USP Heparin Units/mL
Storage temperature (The temperature or range thereof at which the biospecimens were kept until distribution/analysis)	-80 C, 20 to 25 C
Storage duration (The time or range thereof between biospecimen acquisition and distribution or analysis)	8 days, 5 to 7 years
Shipping temperature (The temperature or range thereof at which biospecimens were kept during shipment or relocation)	-170 C to -190 C
Composition assessment & selection (Parameters used to choose biospecimens for the study)	Minimum 80% tumour nuclei & maximum 50% necrosis

[noemide]

04.09. Meeting: Seems to be unknown in Europe.

[noemide]

• [ ] @CeciliaEngels Will create mapping table and report in KDS Meeting.